C

Cooper Companies Inc
BMV:COO

Watchlist Manager
Cooper Companies Inc
BMV:COO
Watchlist
Price: 1 880 MXN -10.13% Market Closed
Market Cap: 19.7B MXN
Have any thoughts about
Cooper Companies Inc?
Write Note

Cooper Companies Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cooper Companies Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
Cooper Companies Inc
BMV:COO
Accounts Receivables
$717m
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
10%
Haemonetics Corp
NYSE:HAE
Accounts Receivables
$213.5m
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
4%
ICU Medical Inc
NASDAQ:ICUI
Accounts Receivables
$174m
CAGR 3-Years
14%
CAGR 5-Years
-4%
CAGR 10-Years
17%
Align Technology Inc
NASDAQ:ALGN
Accounts Receivables
$1B
CAGR 3-Years
6%
CAGR 5-Years
14%
CAGR 10-Years
23%
Lantheus Holdings Inc
NASDAQ:LNTH
Accounts Receivables
$329.3m
CAGR 3-Years
73%
CAGR 5-Years
52%
CAGR 10-Years
23%
Merit Medical Systems Inc
NASDAQ:MMSI
Accounts Receivables
$189.8m
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
11%
No Stocks Found

Cooper Companies Inc
Glance View

Market Cap
19.7B MXN
Industry
Health Care

In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.

COO Intrinsic Value
14 087.38 MXN
Undervaluation 87%
Intrinsic Value
Price
C

See Also

What is Cooper Companies Inc's Accounts Receivables?
Accounts Receivables
717m USD

Based on the financial report for Oct 31, 2024, Cooper Companies Inc's Accounts Receivables amounts to 717m USD.

What is Cooper Companies Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
10%

Over the last year, the Accounts Receivables growth was 18%. The average annual Accounts Receivables growth rates for Cooper Companies Inc have been 12% over the past three years , 10% over the past five years , and 10% over the past ten years .

Back to Top